Community
Company
News
Contact Us
Sign in

Please select the option that best describes you:

Topics: Infectious Disease • Transplant Infectious Disease

Do you routinely discuss the risks of home composting with immunocompromised patients?

Related Questions

What factors influence your decision to initiate antifungal treatment in asymptomatic lung transplant recipients colonized with Aspergillus?

How do you approach duration of antibiotic therapy in a patient with persistent neutropenia and a known, clinically diagnosed bacterial infection?

What is your approach to management of mycoplasma pneumonia in heavily immunosuppressed patients?

How do you manage increasing EBV viremia of 15,000 copies in a seropositive heart transplant recipient with transplant performed 15 years ago in a patient who is otherwise asymptomatic?

How do you approach using fecal microbiota therapy for recurrent Clostridioides difficile infection in immunocompromised patients?

What drug and specific dosing would you use for secondary pneumocystis prophylaxis in a patient with renal transplant, documented TMP-SMX allergy, and normal G6PD testing, who was diagnosed with moderate PJP and improved on clindamycin/primaquine and steroids?

How has your approach to managing asymptomatic bacteriuria in kidney transplant patients changed in light of a recent meta-analysis showing no significant differences in pyelonephritis, symptomatic UTI, or graft loss between patients treated with antibiotics and those who were not treated?

How should the timing of RSV vaccination be managed for patients who undergo stem cell transplant during periods of high community transmission?

For how long would you treat a patient with latent TB before allowing them to proceed with a liver transplant?

Do you manage antibacterials for enterococcal bacteremia differently in patients with severe immunosuppression?

Copyright © 2026 theMednet
All Rights Reserved.